Drug · DIN 02519348
HYDROXYCHLOROQUINE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 18, 2022; first marketed April 18, 2022.
- Drug Identification Number (DIN)
- 02519348
- Company (DIN owner)
- Sanis Health Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Hydroxychloroquine P01BA02
- Class
- Human
- Record last updated
- July 2, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| HYDROXYCHLOROQUINE SULFATE | 200 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 26, 2021: NOC 26506Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Companies